Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries, Inc. is a leading global specialty generic pharmaceutical company headquartered in Mumbai, India. Established in 1983, it has grown to become the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company worldwide. The company reports global revenues of approximately US$5.4 billion.

Sun Pharma manufactures and markets a diverse portfolio of pharmaceutical formulations and active pharmaceutical ingredients (APIs) across more than 100 countries. Their product range includes:

• Generics and branded generics
• Specialty and complex products
• Over-the-counter (OTC) medications
• Antiretrovirals (ARVs) and APIs

These products cover therapeutic areas including neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, nephrology, and respiratory medicine.

Manufacturing Facilities

The company operates 43 manufacturing facilities globally, spanning India, the United States, Asia, Africa, Australia, and Europe.

In the United States, Sun Pharma has a significant presence with facilities including:

• U.S. headquarters in Princeton, New Jersey
• Distribution and customer service teams in Cranbury, New Jersey
• Manufacturing sites in Bryan, Ohio, and Detroit, Michigan
• Operations in Billerica, Massachusetts

Research and Development

Sun Pharma is committed to innovation, investing 6–8% of its global revenues annually in research and development (R&D). Its R&D team consists of over 2,800 professionals working to develop generics and technologically complex products.

Products in development include liposomal drugs, inhalers, lyophilized injections, nasal sprays, and controlled-release dosage forms.

Strategic Acquisitions

In recent years, Sun Pharma has expanded globally through significant acquisitions:

• 2014 acquisition of Ranbaxy Laboratories, boosting its U.S. market presence
• March 2023 acquisition of U.S.-based Concert Pharmaceuticals for $576 million

Workforce and Global Reach

With over 41,000 employees worldwide, Sun Pharmaceutical Industries, Inc. continues to deliver high-quality, affordable medicines and maintain the trust of healthcare professionals and patients globally.

Locations

• Orlando, FL, USA
• Las Vegas, NV, USA
• Princeton, New Jersey, USA
• Cranbury, New Jersey, USA
• Billerica, Massachusetts, USA
• Bryan, Ohio, USA
• Detroit, Michigan, USA
• Mumbai, India